251 related articles for article (PubMed ID: 17939102)
1. Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin.
Werz O
Planta Med; 2007 Oct; 73(13):1331-57. PubMed ID: 17939102
[TBL] [Abstract][Full Text] [Related]
2. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase[sol ]cyclooxygenase.
Schneider I; Bucar F
Phytother Res; 2005 Feb; 19(2):81-102. PubMed ID: 15852496
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
Drazen JM
Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
[TBL] [Abstract][Full Text] [Related]
4. Development of 5-lipoxygenase inhibitors--lessons from cellular enzyme regulation.
Werz O; Steinhilber D
Biochem Pharmacol; 2005 Aug; 70(3):327-33. PubMed ID: 15907806
[TBL] [Abstract][Full Text] [Related]
5. New developments in natural products-based anti-AIDS research.
Yu D; Morris-Natschke SL; Lee KH
Med Res Rev; 2007 Jan; 27(1):108-32. PubMed ID: 16888749
[TBL] [Abstract][Full Text] [Related]
6. Lipoxygenase inhibitors from natural plant sources. Part 2: medicinal plants with inhibitory activity on arachidonate 12-lipoxygenase, 15-lipoxygenase and leukotriene receptor antagonists.
Schneider I; Bucar F
Phytother Res; 2005 Apr; 19(4):263-72. PubMed ID: 16041764
[TBL] [Abstract][Full Text] [Related]
7. On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance.
Siemoneit U; Pergola C; Jazzar B; Northoff H; Skarke C; Jauch J; Werz O
Eur J Pharmacol; 2009 Mar; 606(1-3):246-54. PubMed ID: 19374837
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4 synthase.
Gupta N; Nicholson DW; Ford-Hutchinson AW
Can J Physiol Pharmacol; 1997; 75(10-11):1212-9. PubMed ID: 9431445
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options for 5-lipoxygenase inhibitors.
Werz O; Steinhilber D
Pharmacol Ther; 2006 Dec; 112(3):701-18. PubMed ID: 16837050
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel 2-amino-5-hydroxyindole derivatives that inhibit human 5-lipoxygenase.
Landwehr J; George S; Karg EM; Poeckel D; Steinhilber D; Troschuetz R; Werz O
J Med Chem; 2006 Jul; 49(14):4327-32. PubMed ID: 16821792
[TBL] [Abstract][Full Text] [Related]
11. The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease.
Poeckel D; Funk CD
Cardiovasc Res; 2010 May; 86(2):243-53. PubMed ID: 20093252
[TBL] [Abstract][Full Text] [Related]
12. 5-Lipoxygenase inhibitors: a review of recent patents (2010-2012).
Hofmann B; Steinhilber D
Expert Opin Ther Pat; 2013 Jul; 23(7):895-909. PubMed ID: 23600432
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the search for novel 5-lipoxygenase inhibitors.
Steinhilber D; Hofmann B
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):70-7. PubMed ID: 23953428
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol and its anionic derivatives inhibit 5-lipoxygenase activation in polymorphonuclear leukocytes and MonoMac6 cells.
Aleksandrov DA; Zagryagskaya AN; Pushkareva MA; Bachschmid M; Peters-Golden M; Werz O; Steinhilber D; Sud'ina GF
FEBS J; 2006 Feb; 273(3):548-57. PubMed ID: 16420478
[TBL] [Abstract][Full Text] [Related]
15. 5-Lipoxygenase inhibitors: a review of recent developments and patents.
Pergola C; Werz O
Expert Opin Ther Pat; 2010 Mar; 20(3):355-75. PubMed ID: 20180620
[TBL] [Abstract][Full Text] [Related]
16. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
Sharma JN; Mohammed LA
Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
[TBL] [Abstract][Full Text] [Related]
17. Spice phenolics inhibit human PMNL 5-lipoxygenase.
Prasad NS; Raghavendra R; Lokesh BR; Naidu KA
Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):521-8. PubMed ID: 15120715
[TBL] [Abstract][Full Text] [Related]
18. Lipoxygenase Inhibitors as Cancer Chemopreventives: Discovery, Recent Developments and Future Perspectives.
Mahboubi-Rabbani M; Zarghi A
Curr Med Chem; 2021; 28(6):1143-1175. PubMed ID: 31820690
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of leukotriene synthesis in intact polymorphonuclear cells by the 5-lipoxygenase inhibitor 3-oxo-tirucallic acid.
Boden SE; Schweizer S; Bertsche T; Düfer M; Drews G; Safayhi H
Mol Pharmacol; 2001 Aug; 60(2):267-73. PubMed ID: 11455013
[TBL] [Abstract][Full Text] [Related]
20. 5-lipoxygenase: cellular biology and molecular pharmacology.
Werz O
Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):23-44. PubMed ID: 14561204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
